Core Viewpoint - The company expects a reduction in losses for the fiscal year 2025 compared to the previous year, indicating a potential improvement in financial performance despite ongoing challenges [1] Financial Performance - The company anticipates a net loss attributable to shareholders of between -70 million and -58 million yuan for 2025, which represents a decrease in losses of 10.66 million to 22.66 million yuan compared to the previous year, narrowing the loss by 13.22% to 28.10% [1] - The expected net loss after excluding non-recurring gains and losses is projected to be between -72 million and -60 million yuan, with a reduction in losses of 11.55 million to 23.55 million yuan year-on-year, reflecting a narrowing of losses by 13.83% to 28.19% [1] Operational Strategy - The company is focusing on its core strategy and is coordinating various business operations, although some key projects have experienced delays, impacting revenue recognition and delivery as originally planned [1] - The company is actively working to accelerate the implementation, delivery, and acceptance of related projects, taking measures to mitigate the impact of project delays and ensure the smooth advancement of future operational plans [1]
兴图新科(688081.SH):预计2025年度同比亏损收窄13.22%到28.10%